Essay About Mercure Drug Company And Following Aspects

Information Technology Management Case Study
Managing Information Resources Angelo H. Catubig
A Case Study CBA Program Batch 12
Given:
Mercure Drug Company
Global Pharmaceutical Firm
Fortune Most Admired firm
Cumulative Annual Growth Rate: 15% for five years
48,000 employees
160 countries, 8 R&D laboratories and 30 Global MFG and Supply sites
4 divisions
Pharmaceutical – 57%
Consumer Health – 24%
Animal Care – 11%
MFG – 8%
Focus Market: Asia Pacific (67% of its consolidated revenue)
3 of Mercures blockbuster drugs will lose patent in 24 months
Strategy is to form alliances with other drug companies and buy out potential competitors
Projects
Details
Capital
Risks/Benefits
Sales Force Automation
8.2 M
46 months
Needs standardization which could affect over-all sales
Customer Relationship Mgt.
6.0 M
72 months
Innovation and no competitor has ventured into this strategy
Customer Health internet Data Mine
4.7 M
48 months at most
Only risk is that web users are very sensitive about information being collected and may create backlash from activist shareholders
Animal Health: WOM
76 months
Cheapest but very complicated and would incur additional logistic costs, could contribute to at least 18% growth in the coming years
Global and MFG Supply:JIT Concept
8.0 M
72 months
Can significantly improve cash flow, but needs to implement a major change in the organization
Required :
2 projects that I will sponsor
In order to maintain competitiveness of Mercure we need to consider the following aspects in order to come up with the best IS strategies:
The company will focus on Asia Pacific market since majority of its sales are happening in this region
APAC includes China, SEA and other emerging countries which could be considered as significant markets with the greatest opportunities for growth
Though